KRISTIE GREEAR: Open Payments
NPI 1710492590 · DEARBORN, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$704 in 28 payments from 8 companies in 2025. Trend: 2023 $2,799 · 2024 $3,259 · 2025 $704
Food & beverage: $704
| Company | Payments | Amount |
|---|---|---|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 5 | $236 |
| Alnylam Pharmaceuticals Inc. | 12 | $236 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $81 |
| Novo Nordisk Inc | 2 | $47 |
| Novartis Pharmaceuticals Corporation | 2 | $36 |
| AstraZeneca Pharmaceuticals LP | 1 | $32 |
| Esperion Therapeutics, Inc. | 1 | $19 |
| Amgen Inc. | 1 | $17 |
Products named: LifeVest, AMVUTTRA, JARDIANCE, Wegovy, LEQVIO, WAINUA, NEXLETOL, REPATHA.
Industry payments across MI — which companies pay providers there.
